StockData
Ensysce Biosciences, Inc. logo

Ensysce Biosciences, Inc. (ENSC) shareholders

ENSCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$0.38−0.03 (-6.28%)

Close on Nov 17, 2026Market cap $7.47MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
4.7%
1M of 19M shares
Institutional holders
18
5 new, 2 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
2 buys · 0 sales
Net bought $444.13K

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Bob Gene Gower1,206,5766.10%13D (active) amendmentAug 7, 2026
Joseph Edelman
Joint filing with Perceptive Advisors LLC (5.30%), Perceptive Life Sciences Master Fund, Ltd. (5.30%)
86,6665.30%13G (passive) amendmentMar 31, 2025

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of ENSCValueChange% of portfolio
Jane Street Group, LLC208,8331.07%$60.56K+195,2630.00%
Adage Capital Partners Gp, L.L.C.149,7110.77%$43.42K–0.00%
Virtu Financial LLC95,3910.49%$28.00K+82,0780.00%
Perceptive Advisors LLC86,6660.45%$25.13K–0.00%
Citadel Advisors LLC86,1930.44%$25.00K+28,8300.00%
XTX Topco Ltd77,0050.40%$22.33K+52,6420.00%
Geode Capital Management, LLC62,1880.32%$18.03K−11,6920.00%
Hrt Financial LP54,4290.28%$15.00KNew0.00%
Susquehanna International Group, Llp34,2800.18%$9.94KNew0.00%
Tru Independence Asset Management 2, LLC13,0000.07%$3.77K–0.00%
Two Sigma Securities, LLC12,9530.07%$3.76KNew0.00%
Vanguard Capital Management LLC12,8540.07%$3.73K–0.00%
Tower Research Capital LLC (TRC)6,0940.03%$1.77K–0.00%
FNY Investment Advisers, LLC3,0000.02%$0–0.00%
Barclays PLC1,4400.01%$418New0.00%
SBI Securities Co., Ltd.6410.00%$186+1550.00%
BlackRock, Inc.650.00%$19–0.00%
Clear Street Group Inc.10.00%$0New0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026181M4.7%5 / 51 / 20M0M
Q1 2026150M2.5%6 / 50 / 70M0M
Q4 2025171M2.6%5 / 71 / 50M0M
Q3 2025170M1.8%8 / 32 / 20M0M
Q2 2025110M0.9%4 / 21 / 20M0M
Q1 202590M1.8%2 / 40 / 10M0M
Q4 202480M0.7%8 / 00 / 00M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

3 funds held ENSC in Q1 2026, 38% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of ENSCValue% of fundAs of
Fidelity Extended Market Index Fund72,4540.37%$20.36K0.00%May 31, 2026
Vanguard Extended Market Index Fund12,8540.07%$3.73K0.00%Jun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
James William MorrisonPresident, Director––Aug 10, 2026
Bob G. GowerDirector916,7404.71%Aug 18, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Bob G. Gower
Director
Aug 7, 2026Buy+400,000$0.50$200.00K916,740
Bob G. Gower
Director
Apr 23, 2026Buy+508,614$0.48$244.13K516,740
Bob G. Gower
Director
Mar 2, 2023Buy+90,287$0.49$44.24K1,222,682
Bob G. Gower
Director
Mar 1, 2023Buy+270,000$0.48$129.60K1,132,395
Bob G. Gower
Director
Feb 28, 2023Buy+109,300$0.49$53.56K862,395
Bob G. Gower
Director
Dec 9, 2022Buy+357,143$1.40$500.00K753,095
Lynn Kirkpatrick
Chief Executive Officer, Director
May 26, 2022Buy+27,000$0.53$14.31K381,851
Lynn Kirkpatrick
Chief Executive Officer, Director
May 25, 2022Buy+70,000$0.49$34.30K354,851
Lynn Kirkpatrick
Chief Executive Officer, Director
Jun 30, 2021Award+284,851––284,851
Bob G. Gower
Director, 10% owner
Jun 30, 2021Award+7,919,026––7,919,026
David Carl Humphrey
Chief Financial Officer
Jun 30, 2021Award+50,000––50,000
William H. Chang
Director, 10% owner
Jun 30, 2021Award+2,242,189––2,242,189
William H. Chang
Director, 10% owner
Jun 30, 2021Award+353,451––353,451
Stanley Morgan
10% owner
Jun 19, 2020Sale−776,290––0
Lane Capital Partners LLC Matthews
–
Jan 15, 2018Other−171,832––1,128,370
Eric Carrera
Senior Vice President
Jan 15, 2018Other−8,330––54,701
HG Vora Capital Management, LLC
10% owner
Jan 15, 2018Other−375,000––3,462,500
A. Lorne Weil
Executive Chairman, Director
Jan 15, 2018Other−40,645––266,900
A. Lorne Weil
Executive Chairman, Director
Jan 15, 2018Other−132,158––867,842
George Peng
Chief Financial Officer
Jan 15, 2018Other−13,251––87,014
Eric Carrera
Senior Vice President
Dec 5, 2017Other−1,465––63,031
Daniel B. Silvers
Chief Executive Officer, Director
Dec 5, 2017Other−359,869––1,300,202
HG Vora Capital Management, LLC
10% owner
Dec 5, 2017Other−718,750––2,837,500
A. Lorne Weil
Executive Chairman, Director
Dec 5, 2017Other−187,166––307,545
A. Lorne Weil
Executive Chairman, Director
Dec 5, 2017Other−169,517––1,000,000
George Peng
Chief Financial Officer
Dec 5, 2017Other−733––100,265
HG Vora Capital Management, LLC
10% owner
Dec 1, 2017Buy+1,000,000$10.00$10.00M3,837,500

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
0.49%
0M shares short
Days to cover
1.0
At 0M shares a day
Change since last report
-70.8%
From 0M shares
Short volume, 20 days
25.2%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Ensysce Biosciences's stock actually held short. Settlement fails (shares not delivered on time) peaked at 111,316 shares on Oct 9, 2026 over the last 90 days.

See a number that looks wrong?